FDA Import Refusal SCS-0677010-6/12/1 — APSIN PHARMACEUTICAL LTD
The FDA refused shipment SCS-0677010-6/12/1 from APSIN PHARMACEUTICAL LTD (India) on Jun 18, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3280,75
Refusal Details
- Date
- Jun 18, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 118,3280,75